The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Ranibizumab (Lucentis) in neovascular age-related macular degeneration: evidence from clinical trials
Abstract
BACKGROUND: Neovascular age-related macular degeneration (AMD) has a poor prognosis if left untreated, frequently resulting in legal blindness. Ranibizumab is approved for treating neovascular AMD. However, further guidance is needed to assist ophthalmologists in clinical practice to optimise treatment outcomes. METHODS: An international retina expert panel assessed evidence available from prospective, multicentre studies evaluating different ranibizumab treatment schedules (ANCHOR, MARINA, PIER, SAILOR, SUSTAIN and EXCITE) and a literature search to generate evidence-based and consensus recommendations for treatment indication and assessment, retreatment and monitoring. RESULTS: Ranibizumab is indicated for choroidal neovascular lesions with active disease, the clinical parameters of which are outlined. Treatment initiation with three consecutive monthly injections, followed by continued monthly injections, has provided the best visual-acuity outcomes in pivotal clinical trials. If continued monthly injections are not feasible after initiation, a flexible strategy appears viable, with monthly monitoring of lesion activity recommended. Initiation regimens of fewer than three injections have not been assessed. Continuous careful monitoring with flexible retreatment may help avoid vision loss recurring. Standardised biomarkers need to be determined. CONCLUSION: Evidence-based guidelines will help to optimise treatment outcomes with ranibizumab in neovascular AMD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ranibizumab for Neovascular Age-Related Macular Degeneration
Rosenfeld, P. J., Brown, D. M., Heier, J. S., Boyer, D. S., Kaiser, P. K., Chung, C. Y., & Kim, R. Y. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054481 · Cited by 5,886
Global data on visual impairment in the year 2002.
(2004) · Europe PMC (PubMed Central) · Cited by 4,157
Ranibizumab versus Verteporfin for Neovascular Age-Related Macular Degeneration
Brown, D. M., Kaiser, P. K., Michels, M., Soubrane, G., Heier, J. S., Kim, R. Y., Sy, J. P., & Schneider, S. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa062655 · Cited by 3,522
Altman, R., Carreras, L., Díaz, R. S., Figueroa, E. B., Paolasso, E., Parodi, J. C., Cade, J. F., Donnan, G. A., Eadie, M. J., Gavaghan, T. P., et al. (1994) · Cited by 3,322
Prevalence of Age-Related Macular Degeneration in the United States
(2004) · Archives of Ophthalmology · doi:10.1001/archopht.122.4.564 · Cited by 2,736
Pegaptanib for neovascular age-related macular degeneration
Gragoudas, E. S., Adamis, A. P., Cunningham, E. T., Feinsod, M., & Guyer, D. R. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa042760 · Cited by 2,337
Turiel, E. (2007) · Handbook of Child Psychology · doi:10.1002/9780470147658.chpsy0313 · Cited by 2,143
New Visual Acuity Charts for Clinical Research
Ferris, F. L., Kassoff, A., Bresnick, G. H., & Bailey, I. (1982) · American Journal of Ophthalmology · doi:10.1016/0002-9394(82)90197-0 · Cited by 2,142
Brown, D. M., Michels, M., Kaiser, P. K., Heier, J. S., Sy, J. P., & Ianchulev, T. (2009) · Ophthalmology · doi:10.1016/j.ophtha.2008.10.018 · Cited by 1,318
Fung, A. E., Lalwani, G. A., Rosenfeld, P. J., Dubovy, S. R., Michels, S., Feuer, W. J., Puliafito, C. A., Davis, J. L., Flynn, H. W., & Esquiabro, M. (2007) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2007.01.028 · Cited by 972
Rosenfeld, P. J., Moshfeghi, A. A., & Puliafito, C. A. (2005) · Ophthalmic Surgery, Lasers and Imaging Retina · doi:10.3928/1542-8877-20050701-14 · Cited by 904
Regillo, C. D., Brown, D. M., Abraham, P., Yue, H., Ianchulev, T., Schneider, S., & Shams, N. (2008) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2007.10.004 · Cited by 858
FERRARA, N., DAMICO, L., SHAMS, N., LOWMAN, H., & KIM, R. (2006) · Retina · doi:10.1097/01.iae.0000242842.14624.e7 · Cited by 849
Vascular endothelial growth factor in eye disease
Penn, J. S., Madan, A., Caldwell, R. B., Bartoli, M., Caldwell, R. W., & Hartnett, M. E. (2008) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2008.05.001 · Cited by 762
IDIOPATHIC POLYPOIDAL CHOROIDAL VASCULOPATHY (IPCV)
Yannuzzi, L. A., Sorenson, J., Spaide, R. F., & Lipson, B. (2012) · Retina · doi:10.1097/iae.0b013e31823f992a · Cited by 753
Age-Related Macular Degeneration Is the Leading Cause of Blindness . . .
Bressler, N. M. (2004) · JAMA · doi:10.1001/jama.291.15.1900 · Cited by 684
RETINAL ANGIOMATOUS PROLIFERATION IN AGE–RELATED MACULAR DEGENERATION
Yannuzzi, L. A., Negrão, S., IIDA, T., Carvalho, C., Rodriguez-Coleman, H., Slakter, J., Freund, K. B., Sorenson, J., Orlock, D., & Borodoker, N. (2012) · Retina · doi:10.1097/iae.0b013e31823f9b3b · Cited by 660
INDOCYANINE GREEN VIDEOANGIOGRAPHY OF IDIOPATHIC POLYPOIDAL CHOROIDAL VASCULOPATHY
SPAIDE, R. F., YANNUZZI, L. A., SLAKTER, J. S., SORENSON, J., & ORLACH, D. A. (1995) · Retina · doi:10.1097/00006982-199515020-00003 · Cited by 608
The Natural History and Prognosis of Neovascular Age-Related Macular Degeneration
Wong, T., Chakravarthy, U., Klein, R., Mitchell, P., Zlateva, G., Buggage, R., Fahrbach, K., Probst, C., & Sledge, I. (2008) · Ophthalmology · doi:10.1016/j.ophtha.2007.03.008 · Cited by 601
Self-citationWolf-Schnurrbusch, U. E. K., Ceklic, L., Brinkmann, C. K., Iliev, M. E., Frey, M., Rothenbuehler, S. P., Enzmann, V., & Wolf, S. (2009) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.08-2970 · Cited by 424
Self-citationSubgroup Analysis of the MARINA Study of Ranibizumab in Neovascular Age-Related Macular Degeneration
Boyer, D. S., Antoszyk, A. N., Awh, C. C., Bhisitkul, R. B., Shapiro, H., & Acharya, N. R. (2007) · Ophthalmology · doi:10.1016/j.ophtha.2006.10.045 · Cited by 390
Kaiser, P. K., Brown, D. M., Zhang, K., Hudson, H. L., Holz, F. G., Shapiro, H., Schneider, S., & Acharya, N. R. (2007) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2007.08.012 · Cited by 361 · cited 1×
“A subgroup analysis of 12-month ANCHOR study data showed similar results.(28)”
ResultSelf-citationTYPE 3 NEOVASCULARIZATION: The Expanded Spectrum of Retinal Angiomatous Proliferation
FREUND, K. B., -VAN HO, I., BARBAZETTO, I. A., KOIZUMI, H., LAUD, K., FERRARA, D., MATSUMOTO, Y., SORENSON, J. A., & YANNUZZI, L. (2008) · Retina · doi:10.1097/iae.0b013e3181669504 · Cited by 295
Fleckenstein, M., Issa, P. C., Helb, H.-M., Schmitz-Valckenberg, S., Finger, R. P., Scholl, H. P. N., Loeffler, K. U., & Holz, F. G. (2008) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.08-1967 · Cited by 283
Self-citationVERTEPORFIN ROUNDTABLE 2000 AND 2001 PARTICIPANTS, T. O. A.-R. M. D. W. P. T. (. S. G. P. I. (2002) · Retina · doi:10.1097/00006982-200202000-00003 · Cited by 246
Chang, T. S. (2007) · Archives of Ophthalmology · doi:10.1001/archopht.125.11.1460 · Cited by 239
Brown, D. M., & Regillo, C. D. (2007) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2007.06.039 · Cited by 224
Kaiser, P. K., Blodi, B. A., Shapiro, H., & Acharya, N. R. (2007) · Ophthalmology · doi:10.1016/j.ophtha.2007.04.030 · Cited by 217
(2003) · Archives of Ophthalmology · doi:10.1001/archopht.121.9.1253 · Cited by 213
The development of a "reduced logMAR" visual acuity chart for use in routine clinical practice
Rosser, D. A. (2001) · British Journal of Ophthalmology · doi:10.1136/bjo.85.4.432 · Cited by 201
Lowe, J., Araujo, J., Yang, J., Reich, M., Oldendorp, A., Shiu, V., Quarmby, V., Lowman, H., Lien, S., Gaudreault, J., et al. (2007) · Experimental Eye Research · doi:10.1016/j.exer.2007.05.008 · Cited by 167
TEARS OF THE RETINAL PIGMENT EPITHELIUM: An Old Problem in a New Era
CHANG, L. K., & SARRAF, D. (2007) · Retina · doi:10.1097/iae.0b013e3180a032db · Cited by 167
Grisanti, S., & Tatar, O. (2008) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2008.05.002 · Cited by 165
Age-related macular degeneration: economic burden and value-based medicine analysis
Brown, M. M., Brown, G. C., Stein, J. D., Roth, Z., Campanella, J., & Beauchamp, G. R. (2005) · Canadian Journal of Ophthalmology · doi:10.1016/s0008-4182(05)80070-5 · Cited by 159
PARTICIPANTS, V. R. (2005) · Retina · doi:10.1097/00006982-200502000-00002 · Cited by 156
Age-Related Macular Degeneration and Risk for Stroke
Wong, T. Y., Klein, R., Sun, C., Mitchell, P., Couper, D. J., Lai, H. C., Hubbard, L. D., Sharrett, A. R., & Study, F. T. A. R. I. C. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-145-2-200607180-00007 · Cited by 151
Self-citationGROSS, N. E., Aizman, A., BRUCKER, A. J., Klancnik, J. M., & Yannuzzi, L. A. (2005) · Retina · doi:10.1097/00006982-200509000-00005 · Cited by 150
Anti–Vascular Endothelial Growth Factor Pharmacotherapy for Age-Related Macular Degeneration
Ip, M. S., Scott, I. U., Brown, G. C., Brown, M. M., Ho, A. C., Huang, S. S., & Recchia, F. M. (2008) · Ophthalmology · doi:10.1016/j.ophtha.2008.08.012 · Cited by 142
FALKENSTEIN, I. A., Cochran, D. E., Azen, S. P., Dustin, L., Tammewar, A. M., Kozak, I., & Freeman, W. R. (2007) · Ophthalmology · doi:10.1016/j.ophtha.2007.05.028 · Cited by 141
Ranibizumab for the treatment of neovascular age-related macular degeneration: A review
Kourlas, H., & ABRAMS, P. (2007) · Clinical Therapeutics · doi:10.1016/j.clinthera.2007.09.008 · Cited by 117
Age-related macular degeneration and mortality from cardiovascular disease or stroke
Tan, J., Wang, J. J., Liew, G., Rochtchina, E., & Mitchell, P. (2008) · British Journal of Ophthalmology · doi:10.1136/bjo.2007.131706 · Cited by 106
Self-citationJoeres, S., Tsong, J. W., Updike, P. G., Collins, A. T., Dustin, L., Walsh, A. C., Romano, P. W., & Sadda, S. R. (2007) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.07-0179 · Cited by 103
de Bruin, D. M., Burnes, D. L., Loewenstein, J. I., Chen, Y., Chang, S., Chen, T. C., Esmaili, D. D., & de Boer, J. F. (2008) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.07-1553 · Cited by 100
Bressler, N. M. (2009) · Archives of Ophthalmology · doi:10.1001/archophthalmol.2008.562 · Cited by 98
Guidance for the treatment of neovascular age-related macular degeneration
Schmidt-Erfurth, U. M., Richard, G. W., Augustin, A. J., Aylward, G. W., Bandello, F. M., Corcóstegui, B., Cunha-Vaz, J. G., Gaudric, A., LEYS, A. M., & Schlingemann, R. O. (2007) · Acta Ophthalmologica Scandinavica · doi:10.1111/j.1600-0420.2007.00979.x · Cited by 96
Self-citationLiakopoulos, S., Ongchin, S. C., Bansal, A. S., Msutta, S., Walsh, A. C., Updike, P. G., & Sadda, S. R. (2008) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.08-1877 · Cited by 89
Alexander, S. L., Linde‐Zwirble, W. T., Werther, W., Depperschmidt, E. E., Wilson, L., Palanki, R., Saroj, N., Butterworth, S. L., & Ianchulev, T. (2007) · Ophthalmology · doi:10.1016/j.ophtha.2007.09.017 · Cited by 81
Blick, S. K. A., Keating, G. M., & Wagstaff, A. J. (2007) · Drugs · doi:10.2165/00003495-200767080-00007 · Cited by 81
Elman, M. J., Fine, S. L., Murphy, R. P., Patz, A., & Auer, C. (1986) · Ophthalmology · doi:10.1016/s0161-6420(86)33769-2 · Cited by 76
Retinal Pigment Epithelial Tear after Intravitreal Ranibizumab
Bakri, S. J., & Kitzmann, A. S. (2006) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2006.11.047 · Cited by 73
Evolving European guidance on the medical management of neovascular age related macular degeneration
Chakravarthy, U., Soubrane, G., Bandello, F., Chong, V., Creuzot-Garcher, C., Dimitrakos, S. A., Korobelnik, J.-F., Larsen, M., Monés, J., Pauleikhoff, D., et al. (2006) · British Journal of Ophthalmology · doi:10.1136/bjo.2005.082255 · Cited by 72
Self-citationCarvounis, P. E., Kopel, A. C., & Benz, M. S. (2006) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2006.11.028 · Cited by 69
Arias, L., Armadá, F., Donate, J., García-Arumí, J., Giralt, J., Pazos, B., Piñero, A., Martínez, F., Mondéjar, J. J., Ortega, I., et al. (2009) · Eye · doi:10.1038/sj.eye.6703053 · Cited by 67
Patel, P. J., Chen, F. K., Ikeji, F., Xing, W., Bunce, C., da Cruz, L., & Tufail, A. (2008) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.07-1203 · Cited by 61
Growth Features of Choroidal Neovascular Membranes in Age-related Macular Degeneration
Klein, M. L., Jorizzo, P. A., & Watzke, R. C. (1989) · Ophthalmology · doi:10.1016/s0161-6420(89)32741-2 · Cited by 49
Ahlers, C., Golbaz, I., Stock, G., Fous, A., Kolar, S., Prünte, C. F., & Schmidt-Erfurth, U. M. (2008) · Ophthalmology · doi:10.1016/j.ophtha.2008.05.017 · Cited by 43
Self-citationDadgostar, H., & Waheed, N. K. (2008) · Eye · doi:10.1038/eye.2008.86 · Cited by 41
Schmidt-Erfurth, U. M., Wolf, S., & for the PROTECT Study Group (2008) · British Journal of Ophthalmology · doi:10.1136/bjo.2007.135277 · Cited by 40
Self-citationChan, C. K., & LIN, S. G. (2007) · European Journal of Ophthalmology · doi:10.1177/112067210701700432 · Cited by 39
Ranibizumab: The clinician's guide to commencing, continuing, and discontinuing treatment
Amoaku, W. (2009) · Eye · doi:10.1038/eye.2008.241 · Cited by 29
Amoaku, W. M. K. (2008) · Eye · doi:10.1038/eye.2008.1 · Cited by 15
Cited by
Pennington, K. L., & DeAngelis, M. M. (2016) · Eye and Vision · doi:10.1186/s40662-016-0063-5 · Cited by 480
Schmidt-Erfurth, U., Eldem, B., Guymer, R., Korobelnik, J.-F., Schlingemann, R. O., Axer-Siegel, R., Wiedemann, P., Simader, C., Gekkieva, M., & Weichselberger, A. (2011) · Ophthalmology · doi:10.1016/j.ophtha.2010.09.004 · Cited by 387
Self-citationDefining response to anti-VEGF therapies in neovascular AMD
Amoaku, W. M., Chakravarthy, U., Gale, R., Gavin, M., Ghanchi, F., Gibson, J., Harding, S., Johnston, R. L., Kelly, S., Lotery, A., et al. (2015) · Eye · doi:10.1038/eye.2015.48 · Cited by 355
Evaluation of Age-related Macular Degeneration With Optical Coherence Tomography
Keane, P. A., Patel, P. J., Liakopoulos, S., Heussen, F. M., Sadda, S. R., & Tufail, A. (2012) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2012.01.006 · Cited by 280
POLYPOIDAL CHOROIDAL VASCULOPATHY: Evidence-Based Guidelines for Clinical Diagnosis and Treatment
Koh, A. H. C., Chen, L.-J., Chen, S.-J., Chen, Y., Giridhar, A., Iida, T., Kim, H., Lai, T. Y. Y., Lee, W. K., Li, X., et al. (2013) · Retina · doi:10.1097/iae.0b013e3182852446 · Cited by 265
Metadata
- Authors
- Mitchell, P., Korobelnik, J.-F., Lanzetta, P., Holz, F. G., Prunte, C., Schmidt-Erfurth, U., Tano, Y., & Wolf, S.
- Venue
- British Journal of Ophthalmology
- Publisher
- BMJ
- Published
- 2009-05-13
- Volume
- 94
- Issue
- 1
- Pages
- 2-13
- ISSN
- 0007-1161 (ISSN-L)
- OpenAlex
- W2020761135
- Cited by
- 295
- References
- 61
- FWCI
- 37.07
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.